These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6953369)

  • 21. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombosis of ovarian veins in puerperium associated with heparin-induced thrombocytopenia type II].
    Winkler M; Delpiano B; Rath W
    Zentralbl Gynakol; 2000; 122(1):49-52. PubMed ID: 10785951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced thrombocytopenia: a prospective study of 142 patients.
    Kakkasseril JS; Cranley JJ; Panke T; Grannan K
    J Vasc Surg; 1985 May; 2(3):382-4. PubMed ID: 3999228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin-induced thrombocytopenias, arterial and venous thromboses--complications of heparin therapy].
    Baluda MV
    Ter Arkh; 1996; 68(12):19-22. PubMed ID: 9054030
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparin-associated thrombocytopenia with venous thrombosis. A case report.
    Mandt PR; Robinson CA; Sarnoff RB; Colwell CW
    J Bone Joint Surg Am; 1985 Sep; 67(7):1123-4. PubMed ID: 4030832
    [No Abstract]   [Full Text] [Related]  

  • 26. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thromboembolic events in heparin-induced thrombocytopenia].
    Amital H; Shoenfeld Y
    Harefuah; 1994 Dec; 127(11):448-50, 503. PubMed ID: 7806103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial embolism and thrombocytopenia during heparin therapy].
    Hausberg M; Stöber K; Heidenreich S; Koc F; Stenzinger W; Spieker C; Rahn KH
    Schweiz Rundsch Med Prax; 1993 Jun; 82(22):668-71. PubMed ID: 8391714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-associated thrombocytopenia in a patient with polycythemia vera: the importance of a marked drop in platelet count.
    Garcia S; Cervero A; Sanchez M; Colomina P
    Acta Haematol; 1991; 85(3):169-70. PubMed ID: 2042450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopenia.
    Harris K; Nguyen P; Van Cott EM
    Am J Clin Pathol; 2008 Feb; 129(2):282-6. PubMed ID: 18208809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aggregometric study of anti-thrombocyte plasma factor in heparin-induced thrombocytopenia].
    Fazakas B; Sári B; Boda Z; Rák K
    Orv Hetil; 1982 Jan; 123(4):201-5. PubMed ID: 7063238
    [No Abstract]   [Full Text] [Related]  

  • 32. [Heparin and blood platelets].
    Komarnicki M; Kaźmierczak M
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):899-901. PubMed ID: 2487948
    [No Abstract]   [Full Text] [Related]  

  • 33. Beyond the platelet count: heparin antibodies as independent risk predictors.
    Stribling WK; Slaughter TF; Houle TT; Sane DC
    Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased endothelial and platelet soluble selectins in heparin-induced thrombocytopenia associated with thrombosis.
    Cella G; Fabris F; Luzzatto G; Soini B; Sbarai A
    Haematologica; 2001 Aug; 86(8):887-8. PubMed ID: 11524258
    [No Abstract]   [Full Text] [Related]  

  • 35. Outpatient intravenous heparin therapy for antepartum iliofemoral thrombophlebitis.
    Hill WC; Pearson JW
    Obstet Gynecol; 1971 May; 37(5):785-9. PubMed ID: 5091759
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia and thromboembolism in the postoperative period.
    Rizzoni WE; Miller K; Rick M; Lotze MT
    Surgery; 1988 Apr; 103(4):470-6. PubMed ID: 3353858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparin immune thrombocytopenia in a hemodialysis patient. A case report. Literature review].
    Benítez M; González Gómez I; González Carmelo I; Palma A; Cruz S; Rodríguez E; Amián A; Fernández M F; Merino MJ; Fernández G F; Suárez C; Onaindía JM; González J
    Nefrologia; 2007; 27(6):756-60. PubMed ID: 18336108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia in a child.
    Potter C; Gill JC; Scott JP; McFarland JG
    J Pediatr; 1992 Jul; 121(1):135-8. PubMed ID: 1625071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.